TITLE

Gene disasters

AUTHOR(S)
Pickaver, Alan
PUB. DATE
August 1991
SOURCE
New Scientist;8/24/91, Vol. 131 Issue 1783, p57
SOURCE TYPE
Periodical
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor commenting Iain Cubitt and Tina Barsby's arguments in favor of biotechnology, published in the August 17, 1991 issue of the `New Scientist' magazine.
ACCESSION #
10552612

 

Related Articles

  • HIGH-FIBER SUGARCANE. Clarke, S. J. // BioScience;Jul/Aug1983, Vol. 33 Issue 7, p413 

    A letter to the editor is presented in response to the article "Biotechnology in the Third World," by Tineke Bodd� in the October 1982 issue.

  • Greg Koski replies. Koski, Greg // Hastings Center Report;Mar/Apr2005, Vol. 35 Issue 2, p7 

    Presents a response by Greg Koski to a letter to the editor about his article "FDA and the Life-Sciences Industry: Business as Usual," in the September-October 2004 issue.

  • Industrial application fields in microbiology and biotechnology. Büyükuslu, Nihal // Journal of Cell & Molecular Biology;2004, Vol. 3 Issue 2, p117 

    Presents a letter to the editor about industrial application fields in microbiology and biotechnology.

  • ATCC not involved in negotiations with India. Soriano, Jesus // Nature Biotechnology;Jan2006, Vol. 24 Issue 1, p25 

    A letter to the editor is presented in response to the article "Materials Exchange Deal Meager Boost to India's Biotech," by K. S. Jayaraman published in the September 2005 issue.

  • CORNUCOPIA OR PANDORA'S BOX? Fox, Michael W. // BioScience;Jun85, Vol. 35 Issue 6, p330 

    Presents a letter to the editor about biotechnology and public education in response to the article written by Harvey S. Price in the April 1985 issue.

  • Review of Kornberg's The Golden Helix. Haber, Edgar // New England Journal of Medicine;4/11/96, Vol. 334 Issue 15, p994 

    A letter to the editor is presented in response to the article "The golden helix: inside biotech ventures," by R.S. Schwartz in the November 9, 1995 issue.

  • Review of Kornberg's The Golden Helix. Koshland, Daniel E. // New England Journal of Medicine;4/11/96, Vol. 334 Issue 15, p994 

    A letter to the editor is presented in response to the article "The golden helix: inside biotech ventures," by R.S. Schwartz in the November 9, 1995 issue.

  • Review of Kornberg's The Golden Helix. Morris, David // New England Journal of Medicine;4/11/96, Vol. 334 Issue 15, p994 

    A letter to the editor is presented in response to the article "The golden helix: inside biotech ventures," by R.S. Schwartz in the November 9, 1995 issue.

  • Review of Kornberg's The Golden Helix. Hogness, David; Lehman, I. Robert; Baldwin, Robert; Berg, Paul; Kaiser, Dale; Sharp, Phillip; Bishop, J. Michael; Glaser, Robert J. // New England Journal of Medicine;4/11/96, Vol. 334 Issue 15, p994 

    A letter to the editor is presented in response to the article "The golden helix: inside biotech ventures," by R.S. Schwartz in the November 9, 1995 issue.

  • Reply to 'Regulatory frameworks in developing countries'. Longstaff, Colin; Thelwell, Craig; Whitton, Colin // Nature Biotechnology;Apr2005, Vol. 23 Issue 4, p413 

    Presents a response by Halla Thorsteinsdóttir and Abdallah S. Daar to a letter to the editor about an article "Health Biotechnology Innovation in Developing Countries," in the April 2005 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics